FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne Print this page FORT WORTH, Texas (October 4, 2019) Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved Aklief (trifarotene) Cream, 0.005% for the topical treatment… Read More »
“It’s bonkers what’s happened over the past five years,” says Kreena Dhiman from Crawley in West Sussex. When diagnosed with breast cancer in 2013 at 33, she had just settled back into working life after getting married and spending a year backpacking round the world. “I noticed one of my nipples was inverted and when… Read More »
By Jennifer Couzin-FrankelSep. 13, 2019 , 5:15 PM After 8 hours of contentious discussion, an advisory committee to the U.S. Food and Drug Administration (FDA) today endorsed the effectiveness of a first-of-its-kind peanut allergy treatment. By a seven-to-two vote, the panel concluded that the treatment, known as AR101, can reduce allergic reactions from accidental exposure to… Read More »
FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults Print this page London, UK, 26 July 2019: Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces that the U.S. Food and Drug Administration (FDA) has approved its lead product Accrufer® (Feraccru® in… Read More »